ARTICLE | Clinical News
Taxoprexin DHA-paclitaxel: Phase III pivotal
October 7, 2002 7:00 AM UTC
Protarga will begin this quarter an international, pivotal Phase III trial comparing Taxoprexin to dacarbazine as a first-line therapy in 560 patients with metastatic melanoma. Patients will receive i...